Researchers have defined a new genetic disease caused by a mutation in the IVNS1ABP gene. The condition marks a rare ...
Plans to seek FDA submission and approval for first-in-human trials in type 1 diabetes and stiff person syndrome targeted for early 2026 MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Aditxt, Inc. (NASDAQ: ...
The current path to CAR-T cell therapy is, by any measure, a logistical ordeal. A patient’s immune cells must be drawn out of ...
In the intricate regulation of inflammation, metabolic reprogramming and posttranslational modification (PTM) have emerged as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results